drugset / Trial / NCT00984113
Pharmacokinetics of Elinogrel in Healthy Volunteers and Patients With Mild, Moderate, and Severe Renal Impairment
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of the study is to determine the pharmacokinetics and safety of elinogrel and its metabolite in patients with mild, moderate, and severe renal impairment compared to healthy volunteers.
Timeline
- Start
- 2009-09
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Elinogrel | Small molecule | 100 mg | — |
| Background | Aspirin | Small molecule | 81 mg | — |
| Background | Aspirin | Small molecule | 100 mg | — |